Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by the rest of the world. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
| Last: | $31.875 |
|---|---|
| Change Percent: | -0.27% |
| Open: | $31.52 |
| Close: | $31.96 |
| High: | $32 |
| Low: | $31.2326 |
| Volume: | 658,232 |
| Last Trade Date Time: | 03/06/2026 12:45:12 pm |
| Market Cap: | $4,174,798,177 |
|---|---|
| Float: | 123,522,122 |
| Insiders Ownership: | 1.6% |
| Institutions: | 31 |
| Short Percent: | N/A |
| Industry: | Pharmaceuticals |
| Sector: | Healthcare |
| Website: | http://www.indivior.com |
| Country: | GB |
| City: | North Chesterfield |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Indivior PLC (NASDAQ: INDV).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
